Navigation Links
NutraDyne, Inc. Closes Amended Exchange Agreement With Changchun Yongxin Dirui Medical Co., Ltd.
Date:11/30/2007

CITY OF INDUSTRY, Calif., Nov. 30 /PRNewswire-FirstCall/ -- NutraDyne Group, Inc. (OTC Bulletin Board: NTRG), formerly Digital Learning Management Corporation ("Nutradyne"), today announced that it has closed the Amended Exchange Agreement with Changchun Yongxin Dirui Medical Co., Ltd, a China corporation ("Yongxin") and all of the shareholders of Yongxin.

Mr. Yongxin Liu, Chairman and CEO commented, "We are pleased to close the acquisition and to begin executing on our five-year business plan, which includes opening 1,000 medical retail stores within China. We also plan to open stores in the U.S. to promote traditional Chinese medicine." Mr. Liu added, "We plan to expand aggressively as a public company. This growth will be made possible by the continued cooperation of our partners, both in China, and the U.S."

About the Exchange Agreement

In accordance with the Amended Exchange Agreement, Nutradyne issued 21,000,000 shares of newly issued common stock and 5 million shares of Series A Preferred Stock to the Yongxin shareholders or their designees, representing, immediately following closing, 70% of the total issued and outstanding shares of common stock.

In addition, in accordance with the Amended Share Exchange Agreement, the officers and directors of the public company tendered their resignations and appointed Yongxin designees in their stead.

About NutraDyne Group, Inc.

NutraDyne Group, Inc. was originally formed in Changchun, a capital city of Jilin province in mainland China. The company sells a variety of products, both wholesale, and through its retail medical store chain. NutraDyne has a fourteen year operating history that started as a combination of a pharmaceutical wholesale supplier, retail pharmacy chain and third party medical supplier. Today, the company has eleven stores in Northeast China, and two pharmacies (under construction) in the United States. The company's U.S. headquarter is in City of Industry, California. The company maintains 3 regional business offices and a headquarters in China.

The subsidiary Corporations owned by NutralDyne include:

Changchun Yongxin Dirui Medical Co., Ltd.

JilingYongxin Pharmacy Chains

Tianjin Yongxin Pharmacy Chains

Jilin Dingjian Natural & health products Co., Ltd.

Forward-Looking Statements:

This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from any future results described within the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.

Contact:

Nutradyne, Inc.

Samuel Liu

President

1.626.581.9098

http://www.nutradyneusa.com

In China:

Changchun Yongxin Dirui Medical Co., Ltd.

Nanhuan Road. 2152

Changchun, Jilin

Phone: 86-431-85850966

yx@jlyongxin.com


'/>"/>
SOURCE NutraDyne Group, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. HEI, Inc. Closes on Sale of RFID Division Assets
2. Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds
3. Nexia Closes Acquisition of Green Endeavors; Landis Salons On Track to Generate Revenues of $2.2 Million in 2007
4. Actor Joe Pantoliano Discloses Depression; Talks About His Latest Movie and His Sensitive Side
5. Stryker Discloses Informal Inquiry Made by United States Securities and Exchange Commission
6. MediKeeper Closes Series A Financing Round with PacifiCap as Lead Investor
7. Pfizer Closes La Jolla Campus Due to Continuing Fire Emergency
8. NovaBay Pharmaceuticals Closes Initial Public Offering of Common Stock
9. BCP Veterinary Pharmacy Helps Cure Diabetic Cats with BCP PZI(R), the Closest Match to Feline Insulin Available
10. Danaher Closes Subsequent Offering Period for Tektronix; Acquires Over 90% of TEK Shares
11. MM2 Group Closes $1.1 Million Sale
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... Richmond, BC (PRWEB) , ... April 25, 2017 , ... ... patients from Richmond, BC, who live with dental fear and require sedation to receive ... anxiety at ease during various procedures, from hygienic cleanings to oral surgery, at ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... they rely on contracted partners to help with process innovation in drug formulation ... drug formulation experience along with state-of-the-art analytical equipment in support of their development ...
(Date:4/25/2017)... MN (PRWEB) , ... April 25, 2017 , ... Buyers ... and recreational users to dispensaries and head shops –can’t help but be heartened by ... for the tell-tale cannabis odor aptly described as “skunk smell.” At last they ...
(Date:4/25/2017)... ... 25, 2017 , ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley ... in Writing, set to publish in summer 2017. , Dr. Bobrow, MD, FACEP, ... Arizona College of Medicine. He also serves as Medical Director for the Bureau of ...
(Date:4/25/2017)... ... April 25, 2017 , ... Amendia, Inc., designer, developer, and ... partnership with and platinum sponsorship of Global Spine Outreach (“GSO”), a charitable organization ... of complex spine deformity cases, particularly in children. , GSO’s focus is to ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017 Global Surgical Drainage Device ... tubes used to remove excess liquid and air. The ... urine, bile or lymph. Surgical drains are used in ... as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. ... to prevent accumulation of fluid e.g. blood or pus. ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group ... it is developing at Conejo Spectrum Business Park ... to Atara Biotherapeutics, Inc. , a biopharmaceutical ... and life-threatening diseases that have been underserved by ... T-cell therapies for cancer, autoimmune and infectious disease. ...
Breaking Medicine Technology: